Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia

Archives of Physiology and Biochemistry

Volumn 112, Issue 4-5, 2006, Pages 219-227

  Rosenberger, Dorothea ^a   Moshal, Karni S ^a   Kartha, Ganesh K ^a   Tyagi, Neetu ^a   Sen, Utpal ^a   Lominadze, David ^a   Maldonado, Claudio ^a   Roberts, Andrew M ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Arrhythmia; Bradycardia; Calcium channel; Connexin; Contraction; ECM; Heart failure; Integrin; LVH; MMP; Neuronal endothelial myocyte coupling; NMDA; NOS; Peri capillary fibrosis; Relaxation; Sudden cardiac death; Tachycardia; TIMP

Indexed keywords

CALCIUM; COLLAGEN; CONNEXIN 43; ELASTIN; HOMOCYSTEINE; INDUCIBLE NITRIC OXIDE SYNTHASE; METALLOPROTEINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NITRIC OXIDE; SUPEROXIDE;

ENDOTHELIUM; ENDOTHELIUM CELL; HEART; HEART ARRHYTHMIA; HEART FAILURE; HEART RATE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERVOLEMIA; METABOLOMICS; MUSCLE CELL; NERVE CELL; NONHUMAN; REVIEW;

ARRHYTHMIAS, CARDIAC; COLLAGEN; DEATH, SUDDEN, CARDIAC; ENDOTHELIUM, VASCULAR; FIBROSIS; HEART CONDUCTION SYSTEM; HEART RATE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MATRIX METALLOPROTEINASES; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III;

EID: 33845869034     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450601093443     Document Type: Review

References (117)

1. Adalbert R, Engelhardt JI, Siklos L. 2002. Hcy application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo. Acta Neuropathologica 103(5):428-36.
2. Aimes RT, Quigley JP. 1995. MMP-2 is an interstitial collagenase. J Biol Chem 270:5872-6.
3. Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. 2002. Prospective study of C-reactive protein, Hcy and plasma lipid levels as predictors of SCD. Circulation 105(22):2595-9.
4. Arumugam H, Liu X, Colombo PJ, Corriveau RA, Belousov AB. 2005. NMDA receptors regulate developmental gap junction uncoupling via CREB signaling. Nat Neurosci 8(12):1720-6.
5. Barr SD, Gedamu L. 2003. Role of peroxidoxins in Leishmania chagasi survival. Evidence of an enzymatic defense against nitrosative stress. J Biol Chem 278(12):10816-23.
6. Bastide B, Neyses L, Ganten D, Paul M, Willecke K, Traub O. 1993. Gap junction protein connexin-40 is preferentially expressed in vascular endothelial and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ Res 73:1138-49.
7. Bollani G, Ferrari R, Bersatti F, Ferrari M, Cattaneo M, Zighetti MI, Visioli O, Assanelli D. 1999. A hyperhomocysteinemia study in a population with a familial factor for acute MI and SCD at a young age. Cardiologia 44(1):75-81.
8. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. 1994. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265:H176-82.
9. Breukelman S, Mulder EJ, van Oord R, Jonker H, van der Weijden BC, Taverne MA. 2006. Continuous fetal heart rate monitoring during late gestation in cattle by means of Doppler ultrasonography: reference values obtained by computer-assisted analysis. Theriogenology 65(3):486-98.
10. Burke AP, Fonseca V, Kolodgie F, Zieske A, Fink L, Virmani R. 2002. Increased serum Hcy and SCD resulting from cornary atherosclerosis with fibrous plaques. Arterioscler Thromb Vasc Biol 22(11):1936-41.
11. Carroll JF, Tyagi SC. 2005. Extracellular matrix remodeling in heart of homocysteinemic obese rabbit. Am J Hypertens 18(5):692-8.
12. Chen C, Conklin BS, Ren Z, Zhong DS. 2002. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J Surg Res 102(1):22-30.
13. Chen H, Fitzgerald R, Brown AT, et al. 2005. Identification of a Hcy receptor in the peripheral endothelial and its role in proliferation. J Vasc Surg 41(5):853-60.
14. Cheng J, Kaplowitz N. 2004. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic injury. World J Gastroenterol 10(12):1699-708.
15. Cox M, Sood H, Hunt M, Chandler D, Henegar J, Aru G, Tyagi SC. 2002. Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats. Am J Physiol 282:H1197-206.
16. D'Amico M, Di Filippo C, Rossi F. 1999. Arrhythmias induced by myocardial ischemia-reperfusion are sensitive to ionotrophic excitatory amino acid receptor antagonists. Euro J Pharmacol 366(2-3):167-74.
17. DiMicco J, Monroe AJ. 1996. Stimulation of metabotropic glutamate receptors in the dorsomedial hypothalamus elevates heart rate in rats. Am J Physiol 270:R1115-21.
18. Duchen MR. 2004. Role of mitochondria in health and disease. Diabetes 53:S96-102.
19. Farina AR, et al. 2001. Thioredoxin alters the MMP/TIMP balance and stimulates human SK-N-SH neuroblastoma cell invasion. Eur J Biochem 268(2):405-13.
20. Finkelstein JD. 1990. Methionine metabolism in mammals. J Nutr Biochem 1:228-37.
21. Finkelstein JD. 1998. The metabolism of Hcy: pathways and regulation. Eur J Pediatr 157(S-2):S40-4.
22. Folbergrova J. 1994. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats. Exp Neurol 130(2):344-50.
23. Frey U, Muller M, Kuhl D. 1996. A different form of long lasting potentiation revealed in tPA mutant mice. J Neurosci 16(6):2057-63.
24. Fridman O. 1999. Hyperhomocysteinemia: atherosclerosis and neurotoxicity. Acta Physiol Pharmacol Ther Latinoam 49(1):21-30.
25. Frisch SM, Francis H. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619-26.
26. Fukuchi M, Watanabe J, Kumagai K, Katori Y, Baba S, Fukuda K, Yagi T, Iguchi A, Yokoyama H, Miura M, Kagaya Y, Sato S, Tabayashi K, Shirato K. 2001. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 37:1436-42.
27. Fukuda K, Davies SS, Nakajima T, Ong BH, Kupershmidt S, Fessel J, Amarnath V, Anderson ME, Boyden PA, Viswanathan PC, Roberts LJ 2nd, Balser JR. 2005. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res 97(12):1262-9.
28. Gattuso A, Mazza R, Pellegrino D, Tota B. 1999. Endocardial endothelium (EE) mediates luminal acetylcholine-nitric oxide signaling in isolated frog heart. Am J Physiol 276:H633-41.
29. Gehlen H, Marnette S, Rohn K, Stadler P. 2006. Stress echocardiography in warmblood horses: comparison of dobutamine/atropine with treadmill exercise as cardiac stressors. J Vet Intern Med 20(3):562-8.
30. Goth L, Vitai M. 2003. The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients. Free Radic Biol Med 35(8):882-8.
31. Grozdanvic Z, Gossrau R. 1998. Co-localization of NOS I and NMDA receptor-1 at the neuromuscular junction in rat and mouse skeletal muscle. Cell Tissue Res 291(1):57-63.
32. Gu Z, Kaul M, Yan B, Kridel SJ, et al. 2002. S-nitrosylation of MMPs: signaling pathways to neuronal cell death 297:1186-90.
33. Gutstein DE, Morley GE, Tamaddon H, et al. 2001. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin-43. Circ Res 88:333-9.
34. Heil SG, DeVriese AS, Kluijtmans LA, Mortier S, Den Heijer M, Blom HJ. 2004. The role of HHcy in NO and EDHF-mediated vasodilation. Cell Mol Biol 50(8):911-6.
35. Henderson AH, Lewis MJ, Shah AM, Smith JA. 1992. Endothelium, endocardium, and cardiac contraction. Cardiovasc Res 26(4):305-8.
36. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. 2001. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12:1211-7.
37. Hiromasa S, Ikeda T, Kubota K, Hattori N, Coto H, Maldonado C, Kupersmith J. 1988. Ventricular tachycardia and sudden death in myotonic dystrophy. Am Heart J 115:914-5.
38. Ho PI, et al. 2003. Folate deprivation induces neurodegeneration: roles of oxidative stressand increased Hcy. Neurobiol Dis 14(1):32-42.
39. Hoit BD, Takeishi Y, Cox MJ, Gabel M, Kirkpatrick D, Walsh RA, Tyagi SC. 2002. Remodeling of the left atrium in pacinginduced cardiomyopathy. Mol Cell Biochem 238:145-50.
40. Hoppeler H, Kayar SR. 1988. Capillary and oxidative capacity of muscles. News in Physiol Sci 3:113-6.
41. Huang CF, Su MJ. 1999. Positive inotropic action of NMDA receptor antagonist (+)-MK801 in rat heart. J Biomed Sci 6(6):387-98.
42. Hui TY, et al. 2004. Mice lacking thioredoxin interacting protein provide linking cellular redox state to appropriate response to nutritional signals. J Biol Chem 279(23):24387-93.
43. Hunt MJ, Aru GM, Hayden MR, Moore CK, Hoit BD, Tyagi SC. 2002. Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol 283(2):L239-45. An editorial on this paper, L237-38.
44. James TN, Carson NAJ, Froggatt P. 1974. Coronary vessels and conduction system in homocystinuria. Circulation XLIX:367-74.
45. Jara-Prado A, Ortega-Vazquez A, Martinez-Ruano L, Rios C, Santamaria A. 2003. Hcy-induced brain lipid peroxidation: effectsa of NMDA receptor blockade, antidaxidant, treatment and NOS inhibition. Neurotox Res 5(4):237-43.
46. Joseph J, Joseph L, Shekhawat NS, Devi S, et al. 2003. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart & Circ Physiol 285:H679-86.
47. Joseph J, Washington A, Joseph L, Koehler L, Fink LM, et al. 2002. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart & Circulatory 283:H2567-74.
48. Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, Squarcioni CP, McKenna WJ, Thiene G, Basso C, Brousse N, Fontaine G, Saffitz JE. 2004. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 1(1):3-11.
49. Kass DA, Bronzwaer JGF, Paulus WJ. 2004. What mechanisms underlie diastolic dysfunction in heart failure?. Circ Res 94:1533-42.
50. Keating MT. 1995. Genetic approaches to cardiovascular disease. Supravalvular aortic stenosis, Williams syndrome, and long-QT syndrome. Circulation 92(1):142-7.
51. Kim WK. 1999. S-nitrosation ameliorates homocysteine-induced neurotoxicity and calcium responses in primary culture of rat cortical neurons. Neurosci Lett 265(2):99-102.
52. Kitamua H, Yoshida A, Ohnishi Y, Okajima K, et al. 2003. Correlation of connexin-43 expression and late ventricular potentials in nonischemic dialated cardiomyopathy. Circ J 67(12):1017-21.
53. Kraine D, Bai G, Okamoto S, Carlos M, et al. 1998. Synergistic activation of the NMDA receptor subunit 1 promoter by myocyte enhancer factor 3C and sp1. J Biol Chem 273(40):26218-24.
54. Lalo U, Pankratov Y, Kirchhoff F, North RA, Verkhratsky A. 2006. NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes. J Neurosci 26(10):2673-83.
55. Levkau B, Kenagy RD, Karsan A, Weitkamp B, Clowes AW, Ross R, Raines EW. 2002. Activation of metalloproteinases and their association with integrins: apoptotic pathway in human endothelial cells. Cell Death Differ 9:1360-7.
56. Li H, Brodsky S, Kumari S, Valiunas V, Brink P, Kaide J, Nasjletti A, Goligorsky MS. 2002. Paradoxical pver expression and translocation of connexin 43 in Hcy-treated endothelial cells. Am J Physiol 282:H2124-33.
57. Lindsay MM, Maxwell P, Dunn FG. 2002. TIMP-1: a marker of LV diastolic dysfunction and fibrosis in hypertension. Hypertension 40:136-41.
58. Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM. 1998. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem 3;273(27):16993-7.
59. Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC. 2006. Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart & Circulatory Physiol 290:H1206-13.
60. Matsuoka N, Kodama H, Arakawa H, Yamaguchi I. 2002. NMDA receptor blockade by dizocilpine prevents stress-induced sudden death in cardiomyopathic hamsters. Brain Res 944 (1-2):200-4.
61. Mebazaa A, Wetzel R, Cherian M, Abraham M. 1995. Comparison between endothelial and great vessel endothelial cells: morphology, growth, and prostaglandin release. Am J Physiol 268:H250-9.
62. Meighan SE, Meighan PC, Choudhury P, et al. 2006. Effects of ECM-degrading proteases MMP-3 and -9 on spatial learning and synaptic plasticity. J Neurochem 96(5):1227-41.
63. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. 2001. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104(2):174-80.
64. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. 2002. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hyperten 15:157-63.
65. Mizushige K, Yao L, Noma T, et al. 2000. Alteration in LV diastolic filling and accumulation of mycardial collagen at insulin-resistant prediabetic stage of a type 2 diabetic rat model. Circulation 101:899-907.
66. Moshal KS, Tyagi N, Henderson B, Ovechkin AV, Tyagi SC. 2005. Protease activated receptor and endothelial-myocyte uncoupling in chronic heart failure. Am J Physiol Heart Circ Physiol 288(6):H2770-7.
67. Mujumdar VS, Aru GM, Tyagi SC. 2001. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 82(3):491-500.
68. Mujumdar VS, Hayden MR, Tyagi SC. 2000. Homocysteine induces calcium secondary messenger in vascular smooth muscle cells. J Cell Physiol 183:28-36.
69. Mujumdar VS, Tyagi SC. 1999. Temporal Regulation of ECM Components in Transition from Compensatory Hypertrophy to Decompensatory Heart Failure. J Hypertension 17:261-70.
70. Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ III, Spinale FG, Gold MR. 2006. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97(4):532-7.
71. Mungrue IN, Gros R, You X, Pirani A, Azad A, et al. 2002. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 109(6):735-43.
72. Nihei M, Lee JK, Honjo H, Yasui K, et al. 2005. Decreased vagal control over heart rate in rats with right-sided congestive heart failure: downregulation of nNOS. Circ J 69(4):493-9.
73. Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M. 2001. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 104(10):1165-70.
74. Oh JH, et al. 2004. Thioredoxin sectreted unpon UV A irradiation modulates MMP-2 and TIMP in human dermal fibroblasts. Arch Biochem Biophys 423(1):218-26.
75. Palakurthy P, McGraw P, Maldonado C. 1989. Electrocardiographic changes are associated with elevated blood pressure rather than a direct effect of raised intracranial pressure. In: Hoff JT, Betz AL, editors. Intracranial Pressure 7th ed. Berlin, Hildeberg, New York, Tokyo: Springer-Verlag, pp 442-4.
76. Pavlovich ER. 1998. [Connective tissue components of conducting and working myocardium of the sinoatrial region of the heart in patients of various ages with idiopathic long QT syndrome (quantitative evaluation)]. Morfologiia 114(5):45-50. Russian.
77. Pinsky DJ, Patton S, Mesaros S, Brovkovych V, Kubaszewski E, Grunfeld S, Malinski T. 1997. Mechanical Transduction of NO synthesis in the beating heart. Circ Res 81:372-9.
78. Podrid PJ, Myerburg RJ. 2005. Epidemiology and stratification of risk for sudden cardiac death. Clin Cardiol 28(11 Suppl 1):I3-11.
79. Poelzing S, Rosenbaum DS. 2004. Altered connexin-43 expression produces arrhythmia substrate in heart failure. Am J Physiol 287(4):H1762-70.
80. Qureshi I, Chen H, Brown AT, et al. 2005. Hcy-induced vascular dysregulation is mediated by the NMDA receptor. Vasc Med 10(3):215-23.
81. Roberts JT, Wearn JT. 1941. Quantitative changes in the capillary-muscle relationship in human hearts during normal growth and hypertrophy. Am Heart J 16:617-33.
82. Robinson AJ, Bartlett RK, Bass MA, Colbran RJ. 2005. Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin. J Biol Chem. 280(47):39316-23.
83. Rosenberg GA. 2002. Matrix Metalloproteinases in Neuroinflammation. Glia 39:279-91.
84. Rucklidge GJ, Milne G, McGaw BA, Milne E, Robins SP. 1992. Turnover rates of different collagen types measured by isotope ratio mass spectrometery. Biochim Biophys Acta 11:1156-7.
85. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R, Latchman D. 2001. Apoptosis of endothelial cells precedes myocytes cell apoptosis in ischemia/reperfusion injury. Circulation 104:253-256.
86. Senior RM, Griffin GL, Eliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. 1991. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266:7870-5.
87. Shao LE, et al. 2002. Thioredoxin-related regulation of NO/NOS activities. Ann N Y Acda Sci 962:140-50.
88. Shastry S, Tyagi SC. 2004. Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells. J Cell Biochem 93:207-13.
89. Simandle SA, Kerr BA, Lacza Z, Eckman DM, Busija DW, Bari F. 2005. Piglet pial arterioles respond to N-methyl-d-aspartate in vivo but not in vitro. Microvasc Res 70(1-2):76-83.
90. Smith JA, Shah AM, Fort S, Lewis MJ. 1992. The influence of endocardial endothelium on myocardial contraction. Trends in Pharmacological Sci 13:113-6.
91. Sood HS, Cox MJ, Tyagi SC. 2002. Generation of Nitrotyrosine Precedes the Activation of Matrix Metalloproteinase in Left Ventricle of Hyperhomocystenemia Rats. Antioxidant & Redox Signaling 4(5):799-804.
92. Spragg DD, Kass DA. 2005. Controlling the gap: myocytes, matrix and mechanics. Circ Res 96:485-7.
93. Stamenkovic I. 2003. Extracellular matrix remodeling: the role of matrix metalloproteinases. J Pathol 200:448-64.
94. Torres L, Garcia-Trevijano ER, Rodriguez JA, et al. 1999. Induction of TIMP-1 expression in rat hepatic stellate cells: a new role for Hcy in liver fibrosis. Biochim Biophys Acta 1455(1):12-22.
95. Tsai JC, Perrella MA, Yoshizumi M, et al. 1994. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 91:6369-73.
96. Tummalapalli CM, Heath BJ, Tyagi SC. 2001. Tissue inhibitor of metalloproteinase-4 instigates apopotosis in transformed cardiac fibroblasts. J Cell Biochem 80:512-21.
97. Tyagi SC. 1997. Proteinases and myocardial extracellular matrix turnover. Mol Cell Biochem 168:1-12.
98. Tyagi SC, Hayden MR. 2003. Role of nitric oxide in matrix remodeling in diabetes and heart failure. Heart Failure Reviews 8:23-8.
99. Tyagi SC, Hoit BD. 2002. Metalloproteinase in myocardial adapatation and maladaptation. J Cardiovasc Pharmaol & Therapeutics 7(4):241-6.
100. Tyagi SC, Kumar SG, Alla SR, Reddy HK, Voelker DJ, Janicki JS. 1996. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J Cell Physiol 167(1):137-47.
101. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ. 1995. Proteinases and Restenosis in Human Coronary Artery: Extracellular Matrix Production Exceeds the Expression of Proteolytic Activity. Atherosclerosis 116:43-57.
102. Tyagi SC, Ratajska A, Weber KT. 1993. Myocardial matrix metalloproteinases: localization and activation. Mol Cell Biochem 126:49-59.
103. Tyagi SC, Rodriguez W, Patel AM, Roberts AM, Falcone JC, Passmore JC, Fleming JT, Joshua IG. 2005. Hyperhomocysteinemic Diabetic Cardiomyopathy: Oxidative stress, Remodeling, and Endothelial-Myocyte Uncoupling. J Cardiovasc Pharmacol Therapeutics 10(1):1-10.
104. Tyagi N, Sedoris KC, Moshal KS, Ovechkin AV, Tyagi SC. 2005. Mechanisms of Homocysteine-Induced Oxidative stress. Am J Physiol, Heart & Circulatory Physiol 289(6):H2649-56.
105. Tyagi SC, Smiley LM, Mujumdar VS. 1999. Homocyst(e)ine impairs endocardial endothelial function. Canad J Physiol & Pharmacology 77:950-7.
106. Vamvakas S, et al. 1990. Perurbations of intracellular calcium distribution in kidney cells by nephrotoxic haloalkenyl cysteine S-conjugates. Molecular Pharmacology 38(4):455-61.
107. Vincenti VP, Coon CI, Mengshol JA, Yocum S, Mitchell P, Brinckerhoff CE. 1998. Cloning of the gene for interstitial collagenase-3 (MMP-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (MMP-1). Biochem J 331:341-6.
108. Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases:structure, function, and biochemistry. Circ Res 92(8):827-39.
109. Wang J, Morgan JP. 1992. EE modulates myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. Cir Res 70:754-60.
110. Webb PM, Andrews RD, Costa DP, Le Boeuf BJ. 1998. Heart rate and oxygen consumption of northern elephant seals during diving in the laboratory. Physiol Zool 71(1):116-25.
111. Welch GN, Upchurch GR Jr, Farivar RS, Pigazzi A, Vu K, Brecher P, Keaney JF Jr, Loscalzo J. 1998. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2. Proc Assoc Am Physicians 110(1):22-31.
112. Wolin MS, Gupte SA. 2005. Novel roles for nox oxidases in cardiac arrhythmia and oxidized glutathione export in endothelial function. Circ Res 97(7):612-4.
113. Wong CM, Zhou Y, Ng RW, Kung HF, Jin DY. 2002. Cooperation of yeast peroxiredoxins Tsa1p and Tsa2p in the cellular defense against oxidative and nitrosative stress. J Biol Chem 277(7):5385-94.
114. Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L. 2004. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 27;109(3):363-8.
115. Yamamoto M, Hara H, Adachi T. 2000. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett 486(2):159-62.
116. Yang A, Wang XQ, Sun CS, Wei L, Yu SP. 2005. Inhibitory effects of clofilium on membrane currents associated with Ca channels, NMDA receptor channels and Na+, K+-ATPase in cortical neurons. Pharmacology 73(3):162-8.
117. Zhang W, Nwagwu C, Le M, et al. 2003. Increased invasive capacity of connexin-43 overexpressing malignant glioma cells. J Neurosurg 99:1039-46.